Publication related to RSI or an RSI staff member

Plasma concentrations of neurotransmitters and postpartum depression.

To determine associations between postpartum depression (PPD) and plasma neurotransmitters.
 Methods: We conducted a case-control study nested to a prospective cohort established in 3 comprehensive tertiary hospitals in Changsha, Hunan, China from February to September 2007. The Chinese version of the Edinburgh Postnatal Depression Scale (EPDS) was used at 2 weeks postpartum to screen PPD, with a score of 13 or higher as the cut-off for PPD. The women with matched age but without PPD and delivery within 5 years were selected as controls. The levels of plasma monoamine neurotransmitters including serotonin (5-hydroxytryptamine, 5-HT), dopamine (DA), and norepinephrine (NE), and peptide neurotransmitters including neuropeptide Y (NPY) and substance P (SP) in maternal blood samples taken at 2 weeks postpartum were measured and compared between PPD women (n=42) and controls (n=42).
 Results: Plasma levels of 5-HT and NPY were significantly lower while plasma levels of NE and SP were significantly higher in PPD women than those in the controls. For women with PPD, a negative correlation between NPY and NE (r=-0.36, P﹤0.05) was observed.
 Conclusion: There are changes in plasma levels of neurotransmitters in women with PPD, and there are potential interactions between different neurotransmitters.

Authors

  • Xie, Rihua, Xie R, Department of Nursing, Nanhai Hospital, Southern Medical University, Foshan Guangdong 528244, China; McLaughlin Centre for 
Population Health Risk Assessment, University of Ottawa, Ottawa Ontario K1N 6N5, Canada.

  • Xie, Haiyan, Xie H, Department of Aging Industry, 
Changsha Social Work College, Changsha 410004, China.

  • Krewski, Daniel, Krewski D, McLaughlin Centre for 
Population Health Risk Assessment, University of Ottawa, Ottawa Ontario K1N 6N5, Canada.

  • He, Guoping, He G, Department of Community Nursing, 
Xiangya School of Nursing, Central South University, Changsha 410013, China.

YEAR OF PUBLICATION: 2018
SOURCE: Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2018 Mar 28;43(3):274-281. doi: 10.11817/j.issn.1672-7347.2018.03.007.
JOURNAL TITLE ABBREVIATION: Zhong Nan Da Xue Xue Bao Yi Xue Ban
JOURNAL TITLE: Zhong nan da xue xue bao. Yi xue ban = Journal of Central South University. Medical sciences
ISSN: 1672-7347 (Print) 1672-7347 (Linking)
VOLUME: 43
ISSUE: 3
PAGES: 274-281
PLACE OF PUBLICATION: China
ABSTRACT:
To determine associations between postpartum depression (PPD) and plasma neurotransmitters.
 Methods: We conducted a case-control study nested to a prospective cohort established in 3 comprehensive tertiary hospitals in Changsha, Hunan, China from February to September 2007. The Chinese version of the Edinburgh Postnatal Depression Scale (EPDS) was used at 2 weeks postpartum to screen PPD, with a score of 13 or higher as the cut-off for PPD. The women with matched age but without PPD and delivery within 5 years were selected as controls. The levels of plasma monoamine neurotransmitters including serotonin (5-hydroxytryptamine, 5-HT), dopamine (DA), and norepinephrine (NE), and peptide neurotransmitters including neuropeptide Y (NPY) and substance P (SP) in maternal blood samples taken at 2 weeks postpartum were measured and compared between PPD women (n=42) and controls (n=42).
 Results: Plasma levels of 5-HT and NPY were significantly lower while plasma levels of NE and SP were significantly higher in PPD women than those in the controls. For women with PPD, a negative correlation between NPY and NE (r=-0.36, P﹤0.05) was observed.
 Conclusion: There are changes in plasma levels of neurotransmitters in women with PPD, and there are potential interactions between different neurotransmitters.
LANGUAGE: eng
DATE OF PUBLICATION: 2018 Mar 28
DATE COMPLETED: 20181101
DATE REVISED: 20181101
MESH DATE: 2018/11/02 06:00
EDAT: 2018/04/28 06:00
STATUS: MEDLINE
PUBLICATION STATUS: ppublish
LOCATION IDENTIFIER: 10.11817/j.issn.1672-7347.2018.03.007 [doi]
OWNER: NLM

Related RSI Experts

Daniel Krewski

Chief Risk Scientist

Dr. Daniel Krewski is Chief Risk Scientist and co-founder of Risk Sciences International (RSI), a firm established in 2006 to bring evidence-based, multidisciplinary expertise to the challenge of understanding, managing, and communicating risk. As RSI’s inaugural CEO and long-time scientific...
Read More about Daniel Krewski